What prognostic factors are important for resected intrahepatic cholangiocarcinoma?
- PMID: 17868336
- DOI: 10.1111/j.1440-1746.2007.05040.x
What prognostic factors are important for resected intrahepatic cholangiocarcinoma?
Abstract
Background and aim: Our aim was to evaluate the predictive factors for survival and disease-free survival of patients with resected intrahepatic cholangiocarcinoma (ICC).
Methods: Between October 1994 and 2005, 97 patients with ICC underwent curative hepatic resection. The tumors in 97 patients were reviewed retrospectively to examine the prognosis of ICC.
Results: The 1-, 3- and 5-year survival rates were 74.9%, 51.8% and 31.1%, respectively. The 1-, 3- and 5-year disease-free survival rates were 21.3%, 6.4% and 2.1%, respectively. Univariate analysis showed that tumor size, tumor number, the gross type, resection margin status, T-stage and lymph node involvement were significant prognostic factors. Multiple tumors and cancer cells in the resection margin were found in multivariate analysis to be significantly related to the prognosis. In the multivariate analysis disease free survival was poor for the patients with a large tumor, multiple lesions, a high CA 19-9 level, cancer in the resection margin, advanced T-stage and lymph node involvement.
Conclusions: The overall 5-year survival rate of ICC was 31.1%. Multiple intrahepatic lesions were a sign of a poor prognosis for ICC. Better survival could be achieved by curative resection with a tumor-free margin.
Similar articles
-
Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.Hepatogastroenterology. 2002 Mar-Apr;49(44):311-6. Hepatogastroenterology. 2002. PMID: 11995440
-
The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.Ann Surg Oncol. 2009 Nov;16(11):3048-56. doi: 10.1245/s10434-009-0631-1. Epub 2009 Jul 22. Ann Surg Oncol. 2009. PMID: 19626372
-
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.Br J Surg. 2002 Dec;89(12):1525-31. doi: 10.1046/j.1365-2168.2002.02268.x. Br J Surg. 2002. PMID: 12445060
-
[Intrahepatic bile duct carcinoma (cholangiocarcinoma)].Nihon Geka Gakkai Zasshi. 1997 May;98(5):484-90. Nihon Geka Gakkai Zasshi. 1997. PMID: 9213313 Review. Japanese.
-
[Surgical treatment of intrahepatic cholangiocarcinoma].Chirurgie. 1997;122(2):88-91. Chirurgie. 1997. PMID: 9238798 Review. French.
Cited by
-
Is Surgical Resection Justified for Advanced Intrahepatic Cholangiocarcinoma?Liver Cancer. 2016 Oct;5(4):280-289. doi: 10.1159/000449339. Epub 2016 Sep 14. Liver Cancer. 2016. PMID: 27781200 Free PMC article.
-
Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study.Oncotarget. 2017 Mar 7;8(10):17246-17257. doi: 10.18632/oncotarget.12825. Oncotarget. 2017. PMID: 27783997 Free PMC article. Clinical Trial.
-
Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts.Front Oncol. 2022 Apr 8;12:832038. doi: 10.3389/fonc.2022.832038. eCollection 2022. Front Oncol. 2022. PMID: 35463346 Free PMC article.
-
Serum levels of preoperative α-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation.Eur J Gastroenterol Hepatol. 2014 May;26(5):553-61. doi: 10.1097/MEG.0000000000000070. Eur J Gastroenterol Hepatol. 2014. PMID: 24589829 Free PMC article.
-
Diagnosis and surgical treatment of intrahepatic hepatolithiasis combined with cholangiocarcinoma.World J Surg. 2014 Aug;38(8):2097-104. doi: 10.1007/s00268-014-2476-4. World J Surg. 2014. PMID: 24519588
MeSH terms
LinkOut - more resources
Full Text Sources
Medical